8SRN

De novo designed transmembrane antiparallel homo-dimer G-X6-G 01322-42

PDB DOI: https://doi.org/10.2210/pdb8SRN/pdb

Classification: DE NOVO PROTEIN
Organism(s): synthetic construct
Expression System: Escherichia coli BL21(DE3)
Mutation(s): No

Deposited: 2023-05-05 Released: 2024-09-04
Deposition Author(s): Golden, J., Dai, X., Mravic, M.
Funding Organization(s): Other private

Experimental Data Snapshot

Method: X-RAY DIFFRACTION
Resolution: 3.27 Å
R-Value Free: 0.254
R-Value Work: 0.253
R-Value Observed: 0.253

wwPDB Validation 3D Report Full Report

This is version 1.0 of the entry. See complete history.

Literature

De Novo Design Reveals Principles of a Common Membrane Protein Structural Building Block: The G-X6-G Motif

Mravic, M., Golden, J., Dai, X., Anderson, C.T.

To be published.

Macromolecule Content

Total Structure Weight: 18.98 kDa
Atom Count: 1,034
Modelled Residue Count: 146
Deposited Residue Count: 180
Unique protein chains: 1

Macromolecules

Find similar proteins by:

(by identity cutoff) | 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Gx6G_denovo_design_01322-42	A, B, C, D, E A, B, C, D, E, F	30	synthetic construct	Mutation(s): 0
Entity Groups
Sequence Clusters	30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

Method: X-RAY DIFFRACTION
Resolution: 3.27 Å
R-Value Free: 0.254
R-Value Work: 0.253
R-Value Observed: 0.253
Space Group: C 2 2 2₁

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 54.008	α = 90
b = 71.408	β = 90
c = 101.064	γ = 90

Software Package:

Software Name	Purpose
PHENIX	refinement
SCALEPACK	data scaling
HKL-3000	data reduction
PHASER	phasing

Structure Validation

View Full Validation Report

Entry History & Funding Information

Deposition Data

Released Date: 2024-09-04

Deposition Author(s):

Funding Organization	Location	Grant Number
Other private	United States	--

Revision History (Full details and data files)

Version 1.0: 2024-09-04
Type: Initial release

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.